• ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT

INVESTORS

[경제야놀자] 큐로셀, 국내 최초 ‘항암 면역세포 치료제 기술’로 코스닥 상장 성공! (큐로셀 임상개발센터 조수희 / 대표 김건수) / 헬스톡앤뷰

2024/03/23

큐로셀, 국내 최초 ‘항암 면역세포 치료제 기술’로 코스닥 상장 성공! (큐로셀 임상개발센터 조수희 / 대표 김건수) / 헬스톡앤뷰 (youtube.com)

Prev[한국경제TV] 김건수 큐로셀 대표 “국산 CAR-T 치료제 상업화 머지않았다” [현장에서 만난 CEO]
Next[약사공론] 차세대 CAR-T 치료제, 고형암 정복·대량생산 ‘목표’
Copyright 2023. Curocell Inc. All Rights Reserved.
Created by PRESSCAT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.